VFA
RXDX
Values First Advisors’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,101
| Closed | -$225K | – | 399 |
|
|
2023
Q1 | $225K | Sell |
2,101
-4,596
| -69% | -$493K | 0.14% | 131 |
|
|
2022
Q4 | $737K | Sell |
6,697
-1,892
| -22% | -$208K | 0.51% | 60 |
|
|
2022
Q3 | $507K | Buy |
8,589
+682
| +9% | +$40.3K | 0.36% | 83 |
|
|
2022
Q2 | $223K | Buy |
7,907
+1,899
| +32% | +$53.6K | 0.16% | 128 |
|
|
2022
Q1 | $227K | Buy |
+6,008
| New | +$227K | 0.14% | 142 |
|